Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Profound Medical Corp PROF


Primary Symbol: T.PRN

Technology Scientific & Technical Instruments
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:PRN)

Update: Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

GlobeNewswire 11 days ago

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

GlobeNewswire January 8, 2025

Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 6, 2025

Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

GlobeNewswire December 10, 2024

Canadian Investment Regulatory Organization Trade Resumption - PRN

Canada NewsWire December 6, 2024

Canadian Investment Regulatory Organization Trading Halt - PRN

Canada NewsWire December 6, 2024

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

GlobeNewswire December 6, 2024

Profound Medical Announces Proposed Public Offering of Common Shares

GlobeNewswire December 5, 2024

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

GlobeNewswire December 2, 2024
View More News ››

Opinion & Analysis (TSX:PRN)

VIDEO: Treating Prostate Cancer With Less Side Affects

BTV-Business Television June 21, 2016

VIDEO: A New and Innovative Way to Treat Prostate Cancer

BTV-Business Television June 8, 2016
View More Opinion ››

Bullboard Posts (TSX:PRN)

High Capability Low Footprint Digitally Enhanced MRI is here

and has been here for PRN since at least early December, 2024, when it was announced that Profound Medical and Siemens Healthineers were...
HomerAndCompany - 3 days ago

Image processing advances use AI to improve MRI

Simulated contrast-enhanced MRI helps assess prostate cancer
HomerAndCompany - 8 days ago

Q4 Revenue > Double YOY - Capital Equipment vs Recurring?

Revenue growth accelerated through the last quarter of 2024, more than doubling Q4 2023 revenue. That was accomplished despite the fact...
HomerAndCompany - 10 days ago

RE:PRN-TULSA Reimbursement Raised to Urology APC Level 7...

“Quality is remembered long after the price is forgotten” –Aldo Gucci. There was a high price in time & delays paid for the CPT...
HomerAndCompany - January 1, 2025

new insider buy fron marketbeat.com

Profound Medical Corp. (TSE:PRN - Get Free Report) Senior Officer Thomas Michael Tamberrino purchased 13,333 shares of the stock in a...
Possibleidiot01 - December 11, 2024

insider buy from marketbeat.com

Profound Medical Corp. (TSE:PRN - Get Free Report) Director Arun Menawat Dr. acquired 20,000 shares of Profound Medical stock in a...
Possibleidiot01 - December 10, 2024
View more Bullboard ››

Desert Gold Ventures Inc.

Desert Gold Ventures Inc.

Desert Gold Ventures Inc. is a gold exploration and development company which controls the approximately 440 square ...
View More »